🇺🇸 FDA

Intelligence · Clinical Pipeline

Approved programs Pipeline Programs

ClinicalTrials.gov programs marked approved or launched in registry data.

Programs
1,839

Quick answer

NovaPharmaNews tracks 1,839 approved programs pharmaceutical pipeline programs from ClinicalTrials.gov. ClinicalTrials.gov programs marked approved or launched in registry data.

Top sponsors

Page 25 of 39

  1. Probiotics

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Chronic Kidney Disease

    approved other completed

    1 trial

  2. Procaterol

    Otsuka Beijing Research Institute

    Asthma

    approved small molecule completed

    1 trial

  3. Progesterone

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    approved small molecule completed

    1 trial

  4. Progesterone 100 IM/day

    Universal Integrated

    Progesterone Luteal Support in ICSI

    approved small molecule completed

    1 trial

  5. Prograf

    BRIGHT MINDS BIOSCIENCES INC.

    Renal Transplant Rejection

    approved small molecule completed

    1 trial

  6. Programming (CRT-D, ICD OptiVol® and Cardiac Compass® )

    Rhythm Pharmaceuticals Netherlands B.V.

    Heart Failure

    approved other terminated

    1 trial

  7. Propofol

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Urinary Surgery

    approved small molecule completed

    1 trial

  8. Propofol

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Nausea and Vomiting

    approved small molecule completed

    1 trial

  9. Propranolol

    BRIGHT MINDS BIOSCIENCES INC.

    Cigarette Smoking

    approved small molecule completed

    1 trial

  10. Propranolol

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use Disorder

    approved small molecule active

    1 trial

  11. Prothrombin Complex Concentrate, Human

    The First People's Hospital of Lianyungang

    Cardiac Surgical Procedures

    approved small molecule active

    1 trial

  12. Prothrombin complex concentrate (coagulation factors IX, II, VII and X in combination)

    Takeda

    Prothrombin Complex Factor Deficiency

    approved mab completed

    1 trial

  13. Proton Pump Inhibitors

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Upper Gastrointestinal Hemorrhage

    approved small molecule active

    1 trial

  14. Provase

    Chongqing Precision Biotech Co., Ltd

    Pruritus

    approved other completed

    1 trial

  15. Pulse Sequence

    Aspire Biopharma Holdings

    Atrial Fibrillation

    approved other completed

    1 trial

  16. Pulverized ticagrelor sublingually

    COLLEGIUM PHARMACEUTICAL, INC

    Unstable Angina Pectoris

    approved small molecule completed

    1 trial

  17. Purified Cortophin Gel, 40 U

    ANI PHARMACEUTICALS INC

    Gout Arthritis

    approved small molecule active

    1 trial

  18. Qianjin Capsule of Gynaecology

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Pelvic Inflammatory Diseases

    approved small molecule active

    1 trial

  19. Qizhitongluo Capsule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Ischemic Stroke

    approved small molecule completed

    1 trial

  20. Quadrivalent Influenza Vaccine (Split Virion), inactivated

    Sinovac Research and Development Co.,

    Seasonal Influenza

    approved mab completed

    1 trial

  21. Quetiapine and placebo

    BRIGHT MINDS BIOSCIENCES INC.

    Bipolar Disorder

    approved small molecule completed

    1 trial

  22. Quick-Acting Heart Reliever

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Coronary Artery Stenosis

    approved small molecule completed

    1 trial

  23. Qvar

    Teva Pharma GmbH

    Asthma

    approved small molecule terminated

    2 trials

  24. Qvar® (beclometasone dipropionate HFA)

    Teva Pharma GmbH

    Asthma

    approved small molecule completed

    1 trial

  25. RAMIPRIL HOE498

    Sanofi Pasteur

    Coronary Artery Disease

    approved small molecule completed

    1 trial

  26. RDD to Palynziq

    BioMarin Pharmaceutical Australia Pty Ltd

    Phenylketonuria

    approved small molecule active

    1 trial

  27. REPLAGAL

    Takeda

    Fabry Disease

    approved small molecule active

    5 trials

  28. RF Ablation procedure

    Rhythm Pharmaceuticals Netherlands B.V.

    Paroxysmal Atrial Fibrillation

    approved other completed

    1 trial

  29. RIBOCICLIB, Kisqali 200 mg film-coated tablets

    The George Institute

    Hormone receptor–positive (HRpos)/human epidermal growth factor receptor 2–negative (HER2neg) early breast cancer at risk of recurrence

    approved small molecule active

    1 trial

  30. RIMEGEPANT , Capsaicin

    Disc Medicine

    Obesity, Migraine

    approved small molecule active

    1 trial

  31. RINVOQ 45 mg prolonged-release tablets, Placebo to Match Blinded Upadacitinib, Entyvio 300 mg powder for concentrate for solution for infusion

    Takeda

    Chron's Disease

    approved small molecule active

    1 trial

  32. RITALINE L.P. 10 mg, gélule à libération prolongée

    Tour Hekla

    Attention Deficit Disorder with or without Hyperactivity (ADHD) is a neurodevelopmental disorder characterized by disabling symptoms of inattention and/or hyperactivity-impulsivity beginning before the age of 12 with significant personal, social, academic and/or occupational impact (American Psychiatric Association 2013). This disorder, whose prevalence is around 5% in children and adolescents, affects 2.6% of adults (American Psychiatric Association 2013; Song et al. 2021).

    approved small molecule active

    1 trial

  33. RIVAROXABAN , RIVAROXABAN, RIVAROXABAN

    Pari Pharma GmbH

    Patients with excessive supraventricular ectopies or short atrial runs (ESVEA) defined as ≥ 1% premature atrial contractions (PAC) /24 hours or any atrial runs ≥ 20 PACs (but shorter than 30 seconds) on a 24-hour Holter ECG monitoring and CHA2DS2VASC score ≥ 3. Patients with any atrial runs ≥ 20 PACs but shorter than 30 seconds on a 15-21 days Holter ECG monitoring and CHA2DS2VASC score ≥ 3 may also be included in the Short-Run trial.

    approved small molecule active

    1 trial

  34. RIVASTIGMINE, Rivastigmin adhesive plaster 9.5 mg placebo containing 0 mg of rivastigmin, Rivastigmin adhesive plaster 4.6 mg placebo containing 0 mg of rivastigmin, RIVASTIGMINE

    Disc Medicine

    Depression

    approved small molecule active

    1 trial

  35. RIXUBIS: On-Demand

    Takeda

    Hemophilia B

    approved mab completed

    1 trial

  36. RO7034067, Evrysdi 0.75 mg/mL powder for oral solution

    Hoffmann-La Roche

    Spinal Muscular Atrophy (SMA)

    approved small molecule active

    1 trial

  37. ROCTAVIAN 2 × 1013 vector genomes/mL solution for infusion

    BioMarin Pharmaceutical Australia Pty Ltd

    Hemophilia A

    approved small molecule active

    1 trial

  38. ROP

    GlaxoSmithKline

    Parkinson Disease

    approved small molecule completed

    1 trial

  39. ROPIVACAINE , SODIUM CHLORIDE

    Disc Medicine

    Urolithiasis

    approved small molecule active

    1 trial

  40. ROSUVASTATIN AND EZETIMIBE , BEMPEDOIC ACID , ROSUVASTATIN AND EZETIMIBE , ATORVASTATIN AND AMLODIPINE

    The George Institute

    CHRONIC INFLAMMATORY RHEUMATIC DISEASE: rheumatoid arthritis or psoriatic arthritis or axial spondyloarthritis or systemic lupus erythematosus

    approved small molecule active

    1 trial

  41. ROSUVASTATIN, ROSUVASTATIN, ROSUVASTATIN, ROSUVASTATIN, Placebo to KJX839 (Inclisiran sodium) 0 mg/1.5 mL solution for injection in pre-filled syringe, INCLISIRAN

    Novartis Pharmaceuticals

    Hypercholesterolemia

    approved small molecule active

    1 trial

  42. RYMPHYSIA

    Takeda

    Chronic Obstructive Pulmonary Disease (COPD)

    approved mab terminated

    1 trial

  43. Rabbit ATG, (Genzyme)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Aplastic Anemia

    approved small molecule active

    1 trial

  44. Rabipur Pulver und Lösungsmittel zur Herstellung einer Injektionslösung in einer Fertigspritze Tollwut-Impfstoff (inaktiviert), RABIPUR, poudre et solvant pour solution injectable en seringue préremplie. Vaccin rabique (inactivé)., Rabipur poeder en oplosmiddel voor oplossing voor injectie in een voorgevulde spuit.Rabiësvaccin (geïnactiveerd).

    The George Institute

    rabies pre-exposure prophylaxis

    approved small molecule active

    1 trial

  45. Rabipur, BCG VACCINE AJV por és oldószer szuszpenziós injekcióhoz BCG vakcina, fagyasztva szárított

    Disc Medicine

    health volunteerst

    approved small molecule active

    1 trial

  46. Radio-Flu 0,1 - 4 GBq/ml oplossing voor injectie, MIBG (I123) 74 MBq/mL oplossing voor injectie Jobenguaan (123I)

    Disc Medicine

    Transthyretin amyloid cardiomyopathy

    approved small molecule active

    1 trial

  47. Raltegravir

    Merck KGaA, Darmstadt, Germany

    Human Immunodeficiency Virus (HIV) Infection

    approved small molecule completed

    1 trial

  48. Raltitrexed

    The First People's Hospital of Lianyungang

    Head and Neck Squamous Cell Carcinoma

    approved small molecule active

    1 trial

Frequently asked questions

How many Approved programs pipeline programs are in the directory?

1,839 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.